secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOTRICITY INC. (BTCY)
CIK:        0001630113
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001493152-24-029939
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Biotricity receives Nasdaq bid price deficiency notice; 180-day cure period to Jan 22, 2025
--------------------------------------------------------------------------------

- Closing bid price below $1.00 for 30 consecutive business days triggers Nasdaq Listing Rule 5550(a)(2) deficiency.
- Company has until January 22, 2025 to regain compliance with minimum $1.00 closing bid for 10 consecutive days.
- If non-compliant by Jan 22, may receive additional 180-day period to cure, subject to other listing standards.
- Biotricity intends to monitor bid price and consider available options, including a reverse stock split.
- No immediate impact on Nasdaq listing or trading of BTCY common stock.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224029939/0001493152-24-029939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630113/000149315224029939/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-029939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer